Last month Center Assistant Professor Dr. Laura Cabrera presented at the International Neuroethics Society (INS) Annual Meeting in Chicago. The meeting theme, “Mapping Neuroethics: An Expanded Vision” resulted in a gathering of a truly diverse group of scholars, scientists, clinicians, and professionals dedicated to the responsible use of advances in brain science.
Dr. Cabrera participated in the panel “Incapable Patients and Psychiatric Neurosurgery: What do Law and Ethics Have to Say?”, discussing the regulatory and ethical landscape around psychiatric neurosurgery. Additionally, Dr. Cabrera had two posters discussing results from her NEURON collaboration with Dr. Judy Illes (University of British Columbia), and two posters discussing results from her NIH BRAIN Initiative grant on psychiatric electroceutical interventions. Undergraduate research assistants Emily Castillo and Marissa Cortright were there to present the posters discussing results from the developmental stage of the ongoing NIH BRAIN project. They are pictured below with the posters “Public Views About Treating Depression Across Four Treatment Modalities” and “Perceived Invasiveness of Psychiatric Electroceutical Interventions as Treatment for Clinical Depression.”
Michigan State University students Marissa Cortright and Emily Castillo presented a poster at the 9th annual Mid-Michigan Symposium for Undergraduate Research Experiences (Mid-SURE), held July 24 at Spartan Stadium. Their poster, “Perceived Invasiveness of Psychiatric Electroceutical Interventions as Treatment for Clinical Depression,” presented research from an ongoing NIH BRAIN Initiative grant related to the ethical concerns and attitudes toward the use of psychiatric electroceutical interventions (PEIs) in treatment resistant depression.
Cortright and Castillo, who are both majoring in neuroscience, have been working with MSU faculty mentors Laura Cabrera, Robyn Bluhm, Aaron McCright, and Eric Achytes. Their poster specifically addressed the invasiveness of multiple PEIs—electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and adaptive brain implants (ABI)—based on the analysis of semi-structured interviews with Michigan-based psychiatrists. Cortright and Castillo concluded that the results of the interview analysis “suggest that while physical features are key for assessments of invasiveness, psychological, emotional, and lifestyle effects also play an important role.”
Cortright and Castillo both enjoyed the experience of presenting at Mid-SURE. “It provided a positive and engaging environment to share my work on the project as well as develop my professional skills,” said Castillo, adding, “I left the day feeling inspired and excited to keep working on a topic that is not only important me, but relevant and meaningful to many others.”
With attendees and presenters from many institutions and disciplines, Mid-SURE provided an opportunity to share research and network with a wide variety of individuals. “Many people were excited to learn about the PEIs and the potential to help lots of patients with treatment resistant depression,” said Cortright. “I learned that many people were interested in other segments of our project, and were anticipating the further research and results. I also learned that many people had no idea that PEIs even existed, and were extremely interested in the psychiatrist perspective on these therapies.”
“By sharing the research findings, I learned how different backgrounds can influence how data is interpreted across different disciplines,” said Castillo. “For example, I had an interesting conversation with a chemist who was curious about how the use of magnets or electrical stimulation can alter the chemical balance of the brain and how that relates to invasiveness. I thought this was an interesting question and enjoyed learning about how he interpreted the data coming from a chemistry background.”
Castillo continued: “My interactions with the other students and professors sparked great conversations about the stigma surrounding PEIs and mental illness. It reminded me how critical this research is in educating the public and informing future guidelines and policies surrounding these treatments.”
As the second year of the project approaches, Cortright and Castillo look forward to continuing the research and analysis. “I’m looking forward to looking deeper into the other neuroethical considerations and understanding how these topics vary between psychiatrists, patients, and the general public,” shared Castillo.
Please visit the project webpage to learn more about the NIH BRAIN Initiative grant “Is the Treatment Perceived to be Worse than the Disease?: Ethical Concerns and Attitudes towards Psychiatric Electroceutical Interventions,” led by Center Assistant Professor Dr. Laura Cabrera.